Table 3 Community PCP knowledge of OAC therapy in NVAF patients (N = 462)
Knowledge items | yes(%) | no(%) |
|---|---|---|
How to diagnose AF? | 289 (62.55) | 173 (37.45) |
Which score tool can be used to predict stroke risk in AF patients? | 112 (24.24) | 350 (75.76) |
Which score tool can be used to predict bleed risk in AF patients? | 24 (5.19) | 438 (94.81) |
What risk factors does CHADS2 score include? | 75 (16.23) | 387 (83.77) |
What risk factors does CHADS2-VASc score include? | 71 (15.37) | 391 (84.63) |
What risk factors does HAS-BLED score include? | 62 (13.42) | 400 (86.58) |
Which indicator should be monitored in AF patients with warfarin? | 18 (3.90) | 444 (96.10) |
How long should be monitor coagulation function in AF patients with long-term warfarin therapy at a stable period? | 241 (52.16) | 221 (47.84) |
What’s the target range of INR in AF patients with warfarin under 75 years old? | 180 (38.96) | 282 (61.04) |
What’s the target range of INR in AF patients with warfarin over 75 years old? | 90 (19.48) | 372 (80.52) |
Which factor is susceptible to the anticoagulation effect of warfarin? | 159 (34.42) | 303 (65.58) |
What’s the antagonist that antagonize warfarin’s anticoagulation? | 157 (33.98) | 305 (66.02) |
Which of the following AF patients need to adjust warfarin dose? | 136 (29.44) | 326 (70.56) |
Which medication are the new oral anticoagulants (NOAC)? | 86 (18.61) | 376 (81.39) |